Advocacy intelligence hub — real-time data for patient organizations
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation — PHASE1, PHASE2
Rhode Island Hospital — PHASE3
Emergent BioSolutions — PHASE4
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
William Swiderski
DynPort Vaccine Company LLC
Jill Jin
Associate Editor
📍 CHICAGO, IL
Guri Hagberg
Seksjon for hjerneslag
Emilie Ranheim Skytøen
Oslo kommune
Jason S Richardson
Emergent BioSolutions
Huey-Wen Liang
National Taiwan University Hospital